( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
155.32
141.49
143.17
157.2
Total Expenditure
147.15
146.3
147.31
160.89
PBIDT (Excl OI)
8.16
-4.81
-4.14
-3.69
Other Income
0.6
2.68
2.95
1.55
Operating Profit
8.78
-2.13
-1.19
-2.13
Exceptional Items
NA
NA
NA
0.86
Depreciation
6.8
7.77
8.07
8.08
Profit Before Tax
-0.17
-17.43
-16.12
-17.3
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-5.21
-15.33
-15.8
-17.48
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-43.49
-15.45
-15.47
-2.16
Minority Interest
NA
NA
NA
NA
Shares of Associates
-8.49
-8.62
-6.38
-1.56
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-51.97
-24.07
-21.85
-3.73
Equity Capital
108.51
108.51
108.51
108.51
Face Value (IN RS)
10
10
10
10
Calculated EPS
-4.78
-2.21
-2.01
-0.34
Calculated EPS (Annualised)
-19.15
-8.87
-8.05
-1.37
No of Public Share Holdings
3025546
3025546
3025546
3025546
% of Public Share Holdings
27.88
27.88
27.88
27.88
PBIDTM% (Excl OI)
5.26
-3.39
-2.89
-2.34
PBIDTM%
5.65
-1.50
-0.83
-1.36
PBDTM%
4.26
-6.82
-5.62
-5.86
PBTM%
-0.11
-12.31
-11.25
-11.00
PATM%
-3.36
-10.83
-11.03
-11.11